Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to $550.9 million.

  • Bruker's Receivables - Net rose 232.17% to $550.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $550.9 million, marking a year-over-year increase of 232.17%. This contributed to the annual value of $565.5 million for FY2024, which is 1493.9% up from last year.
  • Bruker's Receivables - Net amounted to $550.9 million in Q3 2025, which was up 232.17% from $522.6 million recorded in Q2 2025.
  • In the past 5 years, Bruker's Receivables - Net ranged from a high of $565.5 million in Q4 2024 and a low of $326.0 million during Q1 2021
  • Moreover, its 5-year median value for Receivables - Net was $472.7 million (2022), whereas its average is $461.1 million.
  • In the last 5 years, Bruker's Receivables - Net increased by 15.36% in 2021 and then surged by 2693.25% in 2022.
  • Over the past 5 years, Bruker's Receivables - Net (Quarter) stood at $416.9 million in 2021, then grew by 13.38% to $472.7 million in 2022, then rose by 4.08% to $492.0 million in 2023, then increased by 14.94% to $565.5 million in 2024, then fell by 2.58% to $550.9 million in 2025.
  • Its Receivables - Net was $550.9 million in Q3 2025, compared to $522.6 million in Q2 2025 and $537.8 million in Q1 2025.